780 related articles for article (PubMed ID: 9220352)
1. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
2. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
4. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
7. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
Taki H; Masuda Y; Yoshizumi M; Kitagawa T; Katoh I
Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573
[TBL] [Abstract][Full Text] [Related]
8. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
9. Block of cardiac ATP-sensitive K(+) channels reduces hydroxyl radicals in the rat myocardium.
Obata T; Yamanaka Y
Arch Biochem Biophys; 2000 Jun; 378(2):195-200. PubMed ID: 10860536
[TBL] [Abstract][Full Text] [Related]
10. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
[TBL] [Abstract][Full Text] [Related]
11. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
[TBL] [Abstract][Full Text] [Related]
13. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
[TBL] [Abstract][Full Text] [Related]
14. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
Sargent CA; Smith MA; Dzwonczyk S; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
[TBL] [Abstract][Full Text] [Related]
15. Protective effects against hydrogen peroxide-induced toxicity by activators of the ATP-sensitive potassium channel in isolated rat hearts.
Gan XT; Cook MA; Moffat MP; Karmazyn M
J Mol Cell Cardiol; 1998 Jan; 30(1):33-41. PubMed ID: 9500862
[TBL] [Abstract][Full Text] [Related]
16. The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection.
Fukuda H; Luo CS; Gu X; Guo L; Digerness SB; Li J; Pike MM
J Mol Cell Cardiol; 2001 Mar; 33(3):545-60. PubMed ID: 11181022
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
Grover GJ; Sleph PG; Dzwonczyk S; McCullough JR
J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
[TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
Headrick JP
J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
20. Repetitive acidosis protects the ischemic heart: implications for mechanisms in preconditioned hearts.
Lundmark JA; Trueblood N; Wang LF; Ramasamy R; Schaefer S
J Mol Cell Cardiol; 1999 Apr; 31(4):907-17. PubMed ID: 10329217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
